Inventor · disambiguated record
Geoffrey Guy
Also filed as: GUY GEOFFREY · GUY GEOFFREY W · GUY GEOFFREY WILLIAM
72 granted patents·57 pending applications·2,755 citations·filing 2001–2025
99Inventor score
Files withGW RES LTD60GW PHARMA LTD44JAZZ PHARMACEUTICALS RESEARCH UK LTD11GUY GEOFFREY4WHITTLE BRIAN2
Top patents by PatentIndex Score
129 records- 0199US10709673B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·48 cites·19 claims
- 0298US12427160B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2025·Granted Sep 30, 2025·1 cites·29 claims
- 0398US12064399B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Aug 20, 2024·14 cites·28 claims
- 0498US11963937B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Granted Apr 23, 2024·14 cites·29 claims
- 0598US11766411B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Sep 26, 2023·17 cites·26 claims
- 0698US11701330B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 18, 2023·19 cites·30 claims
- 0798US11633369B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Apr 25, 2023·26 cites·32 claims
- 0898US11590087B2Cannabidiol-type cannabinoid compoundGW RES LTD·Filed 2022·Granted Feb 28, 2023·23 cites·20 claims
- 0998US11446258B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Sep 20, 2022·30 cites·29 claims
- 1098US11357741B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Jun 14, 2022·33 cites·28 claims
- 1198US11311498B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Apr 26, 2022·34 cites·21 claims
- 1298US11154517B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 26, 2021·38 cites·26 claims
- 1398US11154516B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Oct 26, 2021·42 cites·30 claims
- 1498US11096905B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 24, 2021·43 cites·33 claims
- 1598US10966939B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Apr 6, 2021·47 cites·21 claims
- 1698US10849860B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Dec 1, 2020·49 cites·32 claims
- 1798US10765643B2Use of cannabidiol in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Sep 8, 2020·35 cites·15 claims
- 1898US10709671B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Jul 14, 2020·52 cites·24 claims
- 1998US10709674B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·50 cites·20 claims
- 2098US10603288B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Mar 31, 2020·49 cites·28 claims
- 2198US10195159B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2015·Granted Feb 5, 2019·41 cites·5 claims
- 2298US10137095B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Nov 27, 2018·63 cites·8 claims
- 2398US10111840B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 30, 2018·67 cites·14 claims
- 2498US10092525B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Oct 9, 2018·62 cites·8 claims
- 2598US9956185B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·71 cites·11 claims
- 2698US9956186B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·68 cites·11 claims
- 2798US9956183B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·69 cites·18 claims
- 2898US9956184B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted May 1, 2018·67 cites·12 claims
- 2998US9949937B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2017·Granted Apr 24, 2018·64 cites·14 claims
- 3098US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 3198US7025992B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted Apr 11, 2006·110 cites·38 claims
- 3297US12318356B2Use of cannabinoids in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2023·Granted Jun 3, 2025·2 cites·26 claims
- 3397US11406623B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Aug 9, 2022·24 cites·25 claims
- 3497US11400055B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 2, 2022·29 cites·17 claims
- 3597US11160795B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Nov 2, 2021·38 cites·29 claims
- 3697US11065209B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 20, 2021·43 cites·22 claims
- 3797US10918608B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2015·Granted Feb 16, 2021·50 cites·25 claims
- 3897US6730330B2Pharmaceutical formulationsGW PHARMA LTD·Filed 2001·Granted May 4, 2004·98 cites·16 claims
- 3996US12102619B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Oct 1, 2024·7 cites·24 claims
- 4096US11865102B2Cannabidiol preparations and its usesGW RES LTD·Filed 2021·Granted Jan 9, 2024·18 cites·30 claims
- 4196US11419829B2Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Aug 23, 2022·23 cites·17 claims
- 4296US11207292B2Cannabidiol preparations and its usesGW RES LTD·Filed 2020·Granted Dec 28, 2021·47 cites·26 claims
- 4396US10583096B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2017·Granted Mar 10, 2020·35 cites·19 claims
- 4496US9949936B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Granted Apr 24, 2018·54 cites·14 claims
- 4596US9474726B2Use of cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 25, 2016·74 cites·8 claims
- 4696US9066920B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyWHALLEY BEN·Filed 2010·Granted Jun 30, 2015·74 cites·13 claims
- 4796US9017737B2Use of cannabinoids in combination with an anti-psychotic medicamentKIKUCHI TETSURO·Filed 2008·Granted Apr 28, 2015·96 cites·21 claims
- 4896US7622140B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsGW PHARMA LTD·Filed 2002·Granted Nov 24, 2009·107 cites·28 claims
- 4995US11679087B2Use of cannabinoids in the treatment of Angelman syndromeGW RES LTD·Filed 2017·Granted Jun 20, 2023·18 cites·19 claims
- 5095US9034395B2Processes and apparatus for extraction of active substances and enriched extracts from natural productsWHITTLE BRIAN·Filed 2009·Granted May 19, 2015·54 cites·16 claims
Showing the top 50 of 129 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Geoffrey Guy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →